Needham & Company Maintains a 'Buy' on Pluristem Therapeutics (PSTI); Enters into Early-Stage Licensing Agreement Around PLX Cells
Go back to Needham & Company Maintains a 'Buy' on Pluristem Therapeutics (PSTI); Enters into Early-Stage Licensing Agreement Around PLX Cells| PLURISTEM THERAPEUTICS, Inc. (NASDAQ: PSTI) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $1.85 | |||
| Open | $0.00 | 52 Week Low | $0.71 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-0.41 | |||
| Volume | 12 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 499.73 -1.54 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $501.27 | 52 Week High | $164.04 | |||
| Open | $498.91 | 52 Week Low | $97.52 | |||
| Day High | $501.62 | P/E | 91.36 | |||
| Day Low | $494.35 | EPS | $5.47 | |||
| Volume | 472,956 | |||||
